In March 1986, Tamperer contaminated CONTAC cold capsules, the most popular product SmithKline consumer product. To resume CONTAC after removing it from the market, the management team had to submit a plan of action for the corporation board. They knew that a 25 year old brand in CONTAC franchise was built on his image as a capsule with a "tiny time pills" inside, but also acknowledged that the media turn public opinion against all the capsules. Technology that will reduce the vulnerability of capsules or capsules produce a solid alternative was available only through the competition. Consumer and trade promotions solutions also had to be made, and the price effects of the resumption of costs to be addressed. Resumption was to be in place by August 1 of that year, when he was to be at all successful. "Hide
by Thomas J. Kosnik, Jennifer L. Lai Source: Harvard Business School 22 pages. Publication Date: Dec 02, 1987. Prod. #: 588046-PDF-ENG
Related Case Solutions & Analyses:
Liberating Leadership: How the Initiative-Freeing Radical Organizational Form Has Been Successfully Adopted
Service Sabotage: The Dark Side of Service Dynamics
Interview with Philip Casey at AmeriSteel Video
Running and Growing the Small Company Course Overview
Diamond Chemicals PLC (A): The Merseyside Project
Working Capital Management Growth
Internal Competition – A Curse for Team Performance
ESMT European School of Management and Technology
Singapore Management University (SMU)
ASSET RECONSTRUCTION COMPANIES IN INDIA – CHALLENGES AND OPPORTUNITIES
